FactorPad
Build a Better Process

Stock Risk Measures for Editas Medicine Inc

A quantitative factor review as of September 30, 2021.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: October 05, 2021
See how we arrive at an overall risk score of 66 for EDIT below.

/ factorpad.com / stocks / f71xsj.html


An ad-free and cookie-free website.


EDIT Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Editas Medicine Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how EDIT stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Biological Product (except Diagnostic) Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Identity

Sector and Industry

Share Data

Shares

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f71xsj.html


EDIT stock risk
EDITAS MEDICINE INC stock beta
EDIT risk report
EDIT f71xsj
EDIT risk analysis
EDIT volatility
EDITAS MEDICINE INC credit risk
EDIT liquidity risk
EDIT leverage
EDIT valuation
EDIT systematic risk
EDIT specific risk
EDITAS MEDICINE INC volatility
EDIT analysis
EDIT financial ratio

A newly-updated free resource. Connect and refer a friend today.